BACKGROUND: This study aimed to determine the association between circulating leptin levels and total depressive symptoms as well as depressive symptom dimensions (cognitive and somatic) after controlling for important confounding factors. METHODS: The study sample was comprised of 135 participants with the metabolic syndrome. Depressive symptoms were measured using the Beck Depression Inventory-II. Leptin was measured using a leptin-specific enzyme immunoassay. Inflammation was assessed using C-reactive protein and interleukin-6 levels. RESULTS: Leptin was significantly associated with somatic depressive symptoms (β = 0.33, P = 0.018), but not total depressive symptoms (β = 0.27, P = 0.067) or cognitive depressive symptoms (β = 0.21, P = 0.182), after controlling for age, gender, body mass index, and insulin resistance. Further adjustment for C-reactive protein and interleukin-6 levels did not alter the relationship (β = 0.32, P = 0.023) between circulating leptin levels and somatic depressive symptoms. CONCLUSIONS: Leptin is independently associated with somatic depressive symptoms in patients with the metabolic syndrome.
BACKGROUND: This study aimed to determine the association between circulating leptin levels and total depressive symptoms as well as depressive symptom dimensions (cognitive and somatic) after controlling for important confounding factors. METHODS: The study sample was comprised of 135 participants with the metabolic syndrome. Depressive symptoms were measured using the Beck Depression Inventory-II. Leptin was measured using a leptin-specific enzyme immunoassay. Inflammation was assessed using C-reactive protein and interleukin-6 levels. RESULTS:Leptin was significantly associated with somatic depressive symptoms (β = 0.33, P = 0.018), but not total depressive symptoms (β = 0.27, P = 0.067) or cognitive depressive symptoms (β = 0.21, P = 0.182), after controlling for age, gender, body mass index, and insulin resistance. Further adjustment for C-reactive protein and interleukin-6 levels did not alter the relationship (β = 0.32, P = 0.023) between circulating leptin levels and somatic depressive symptoms. CONCLUSIONS:Leptin is independently associated with somatic depressive symptoms in patients with the metabolic syndrome.
Authors: Julie A Pasco; Felice N Jacka; Lana J Williams; Margaret J Henry; Geoffrey C Nicholson; Mark A Kotowicz; Michael Berk Journal: J Affect Disord Date: 2007-08-28 Impact factor: 4.839
Authors: Angélique A Schiffer; Aline J Pelle; Otto R F Smith; Jos W Widdershoven; Eric H Hendriks; Susanne S Pedersen Journal: J Clin Psychiatry Date: 2009-07-28 Impact factor: 4.384
Authors: Sarah E Linke; Thomas Rutledge; B Delia Johnson; Viola Vaccarino; Vera Bittner; Carol E Cornell; Wafia Eteiba; David S Sheps; David S Krantz; Susmita Parashar; C Noel Bairey Merz Journal: Arch Gen Psychiatry Date: 2009-05
Authors: Kim G Smolderen; John A Spertus; Kimberly J Reid; Donna M Buchanan; Harlan M Krumholz; Johan Denollet; Viola Vaccarino; Paul S Chan Journal: Circ Cardiovasc Qual Outcomes Date: 2009-04-25
Authors: Diana A Chirinos; Indira Gurubhagavatula; Preston Broderick; Julio A Chirinos; Karen Teff; Thomas Wadden; Greg Maislin; Hassam Saif; Jesse Chittams; Caitlin Cassidy; Alexandra L Hanlon; Allan I Pack Journal: J Behav Med Date: 2017-06-21
Authors: Diana A Chirinos; Josefina Medina-Lezama; Belissa Salinas-Najarro; William Arguelles; Maria M Llabre; Neil Schneiderman; Roberto Paz-Manrique; Juan F Bolanos; Zubair Khan; Julio A Chirinos Journal: J Behav Med Date: 2014-09-30